Khiron Life Sciences has recently participated in the Open Parliament held by Senate of Mexico on the theme of "Towards Cannabis Regulation," which took place through August 2019 and September 2019. As a Latin American cannabis company with a strong presence in Mexico, Khiron joined both open forum sessions and a committee of experts to engage in dialogue and provide input on the building blocks of the country's new regulatory framework.
Initiated by Mexico's United Commission of Justice, Health, Second of Legislative Studies and Public Safety, the Open Parliament is a consultation forum which invites the public, including civil society stakeholders and cannabis industry leaders, to discuss five key topics on cannabis regulation and availability. The Senate of Mexico also hosted a series of international speakers, such as former Colombian Senator Juan Manuel Galan, to provide their perspectives and learnings from the legalization process undertaken in other countries. Feedback provided by participants, including Khiron, will serve to inform the country's cannabis legislation, which is currently slated to be passed by the Senate before the end of October 2019. Upon legalization, Mexico will be the most populous market to fully legalize cannabis nationwide, with an industry estimated to be worth $1.2 billion USD by 2028.
"Participation in the Open Parliament builds on Khiron's history of leadership and advocacy in Mexico's cannabis industry," stated Luis Chaves, Country Manager, Mexico at Khiron Life Sciences. "The legalization of medical and adult-use cannabis will be a historic moment for 130 million people across Mexico. We are thrilled to lend our insight and knowledge as the country works to shape its regulatory framework and its developing cannabis industry."
"In Mexico, Khiron is well-positioned to reach the country's consumers and patients, and to play a leading role in the market for cannabis. The company works closely with Centro Fox, founded by former President of Mexico and current board member Vicente Fox, to engage key stakeholders through a program of Khiron-hosted and sponsored events, including the 2nd annual CannaMexico conference held in April 2019. In addition to its relationship with Centro Fox, Khiron has further built a network of partnerships with leading medical associations, with endorsements from the Mexican College of Internal Medicine and Mexican Academy of Neurology."
For more information:
Khiron Life Sciences Corp.
khiron.ca